(GIL) Gildan Activewear - Overview
Exchange: NYSE •
Country: Canada •
Currency: USD •
Type: Common Stock •
ISIN: CA3759161035
Stock: Apparel, Hosiery, Underwear
Total Rating 49
Risk 49
Buy Signal -0.98
| Risk 5d forecast | |
|---|---|
| Volatility | 52.6% |
| Relative Tail Risk | -12.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.74 |
| Alpha | 10.11 |
| Character TTM | |
|---|---|
| Beta | 0.815 |
| Beta Downside | 0.757 |
| Drawdowns 3y | |
|---|---|
| Max DD | 31.28% |
| CAGR/Max DD | 0.93 |
EPS (Earnings per Share)
Revenue
Description: GIL Gildan Activewear March 05, 2026
Gildan Activewear Inc. (GIL) is a Canadian apparel manufacturer. The company produces a range of activewear, hosiery, and underwear products.
GILs product portfolio includes T-shirts, fleece, and polos under brands like Gildan and American Apparel. They also offer socks through brands such as GoldToe and Peds, and underwear under the Gildan brand. The apparel manufacturing sector is characterized by a global supply chain and competitive pricing.
The company distributes its products to wholesale channels, including screenprinters, and directly to retailers across North America, Europe, Asia-Pacific, and Latin America. This business model combines wholesale distribution with direct retail sales. For further detailed analysis, investors can explore Gildans financial performance on ValueRay.
Founded in 1946, Gildan Activewear Inc. operates within the Apparel, Accessories & Luxury Goods GICS Sub Industry.
Headlines to watch out for
- Cotton price fluctuations impact manufacturing costs
- Activewear demand drives wholesale revenue
- North American retail sales influence profitability
- International expansion opens new market opportunities
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 399.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -4.87 > 1.0 |
| NWC/Revenue: 67.94% < 20% (prev 31.22%; Δ 36.72% < -1%) |
| CFO/TA 0.06 > 3% & CFO 590.0m > Net Income 399.7m |
| Net Debt (4.59b) to EBITDA (744.6m): 6.16 < 3 |
| Current Ratio: 2.11 > 1.5 & < 3 |
| Outstanding Shares: last quarter (160.2m) vs 12m ago 3.78% < -2% |
| Gross Margin: 30.99% > 18% (prev 0.31%; Δ 3068 % > 0.5%) |
| Asset Turnover: 51.34% > 50% (prev 88.03%; Δ -36.70% > 0%) |
| Interest Coverage Ratio: 4.76 > 6 (EBITDA TTM 744.6m / Interest Expense TTM 125.8m) |
Altman Z'' 3.01
| A: 0.24 (Total Current Assets 4.70b - Total Current Liabilities 2.23b) / Total Assets 10.45b |
| B: 0.11 (Retained Earnings 1.17b / Total Assets 10.45b) |
| C: 0.08 (EBIT TTM 599.1m / Avg Total Assets 7.08b) |
| D: 0.50 (Book Value of Equity 3.44b / Total Liabilities 6.89b) |
| Altman-Z'' Score: 3.01 = A |
Beneish M -1.64
| DSRI: 1.58 (Receivables 953.9m/542.4m, Revenue 3.63b/3.27b) |
| GMI: 0.99 (GM 30.99% / 30.59%) |
| AQI: 2.45 (AQ_t 0.39 / AQ_t-1 0.16) |
| SGI: 1.11 (Revenue 3.63b / 3.27b) |
| TATA: -0.02 (NI 399.7m - CFO 590.0m) / TA 10.45b) |
| Beneish M-Score: -1.64 (Cap -4..+1) = CCC |
What is the price of GIL shares?
As of March 09, 2026, the stock is trading at USD 62.43 with a total of 2,949,391 shares traded.
Over the past week, the price has changed by -7.08%, over one month by -13.93%, over three months by +8.03% and over the past year by +29.01%.
Over the past week, the price has changed by -7.08%, over one month by -13.93%, over three months by +8.03% and over the past year by +29.01%.
Is GIL a buy, sell or hold?
Gildan Activewear has received a consensus analysts rating of 4.38.
Therefore, it is recommended to buy GIL.
- StrongBuy: 6
- Buy: 6
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the GIL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 83.1 | 33.1% |
| Analysts Target Price | 83.1 | 33.1% |
GIL Fundamental Data Overview March 05, 2026
P/E Trailing = 21.6278
P/E Forward = 15.5039
P/S = 3.4191
P/B = 8.3606
P/EG = 0.6679
Revenue TTM = 3.63b USD
EBIT TTM = 599.1m USD
EBITDA TTM = 744.6m USD
Long Term Debt = 1.30b USD (from longTermDebt, two quarters ago)
Short Term Debt = 508.8m USD (from shortTermDebt, last quarter)
Debt = 4.87b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.59b USD (from netDebt column, last quarter)
Enterprise Value = 16.96b USD (12.37b + Debt 4.87b - CCE 283.9m)
Interest Coverage Ratio = 4.76 (Ebit TTM 599.1m / Interest Expense TTM 125.8m)
EV/FCF = 35.14x (Enterprise Value 16.96b / FCF TTM 482.8m)
FCF Yield = 2.85% (FCF TTM 482.8m / Enterprise Value 16.96b)
FCF Margin = 13.28% (FCF TTM 482.8m / Revenue TTM 3.63b)
Net Margin = 11.00% (Net Income TTM 399.7m / Revenue TTM 3.63b)
Gross Margin = 30.99% ((Revenue TTM 3.63b - Cost of Revenue TTM 2.51b) / Revenue TTM)
Gross Margin QoQ = 28.19% (prev 33.67%)
Tobins Q-Ratio = 1.62 (Enterprise Value 16.96b / Total Assets 10.45b)
Interest Expense / Debt = 0.85% (Interest Expense 41.4m / Debt 4.87b)
Taxrate = 7.82% (4.41m / 56.4m)
NOPAT = 552.3m (EBIT 599.1m * (1 - 7.82%))
Current Ratio = 2.11 (Total Current Assets 4.70b / Total Current Liabilities 2.23b)
Debt / Equity = 1.37 (Debt 4.87b / totalStockholderEquity, last quarter 3.56b)
Debt / EBITDA = 6.16 (Net Debt 4.59b / EBITDA 744.6m)
Debt / FCF = 9.51 (Net Debt 4.59b / FCF TTM 482.8m)
Total Stockholder Equity = 1.97b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.65% (Net Income 399.7m / Total Assets 10.45b)
RoE = 20.31% (Net Income TTM 399.7m / Total Stockholder Equity 1.97b)
RoCE = 18.31% (EBIT 599.1m / Capital Employed (Equity 1.97b + L.T.Debt 1.30b))
RoIC = 17.12% (NOPAT 552.3m / Invested Capital 3.23b)
WACC = 6.62% (E(12.37b)/V(17.25b) * Re(8.92%) + D(4.87b)/V(17.25b) * Rd(0.85%) * (1-Tc(0.08)))
Discount Rate = 8.92% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -3.44%
[DCF] Terminal Value 82.29% ; FCFF base≈430.8m ; Y1≈394.1m ; Y5≈349.1m
[DCF] Fair Price = 21.20 (EV 8.52b - Net Debt 4.59b = Equity 3.92b / Shares 185.2m; r=6.62% [WACC]; 5y FCF grow -10.66% → 2.90% )
EPS Correlation: 38.13 | EPS CAGR: 6.43% | SUE: 0.22 | # QB: 0
Revenue Correlation: 30.08 | Revenue CAGR: 5.63% | SUE: 0.57 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.25 | Chg7d=-0.072 | Chg30d=-0.086 | Revisions Net=-2 | Analysts=8
EPS current Year (2026-12-31): EPS=4.31 | Chg7d=-0.196 | Chg30d=-0.204 | Revisions Net=-7 | Growth EPS=+22.9% | Growth Revenue=+69.5%
EPS next Year (2027-12-31): EPS=5.36 | Chg7d=-0.042 | Chg30d=-0.062 | Revisions Net=-2 | Growth EPS=+24.3% | Growth Revenue=+7.2%
[Analyst] Revisions Ratio: -0.50 (1 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.3% (Discount Rate 8.9% - Earnings Yield 4.6%)
[Growth] Growth Spread = +74.7% (Analyst 79.0% - Implied 4.3%)
P/E Forward = 15.5039
P/S = 3.4191
P/B = 8.3606
P/EG = 0.6679
Revenue TTM = 3.63b USD
EBIT TTM = 599.1m USD
EBITDA TTM = 744.6m USD
Long Term Debt = 1.30b USD (from longTermDebt, two quarters ago)
Short Term Debt = 508.8m USD (from shortTermDebt, last quarter)
Debt = 4.87b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.59b USD (from netDebt column, last quarter)
Enterprise Value = 16.96b USD (12.37b + Debt 4.87b - CCE 283.9m)
Interest Coverage Ratio = 4.76 (Ebit TTM 599.1m / Interest Expense TTM 125.8m)
EV/FCF = 35.14x (Enterprise Value 16.96b / FCF TTM 482.8m)
FCF Yield = 2.85% (FCF TTM 482.8m / Enterprise Value 16.96b)
FCF Margin = 13.28% (FCF TTM 482.8m / Revenue TTM 3.63b)
Net Margin = 11.00% (Net Income TTM 399.7m / Revenue TTM 3.63b)
Gross Margin = 30.99% ((Revenue TTM 3.63b - Cost of Revenue TTM 2.51b) / Revenue TTM)
Gross Margin QoQ = 28.19% (prev 33.67%)
Tobins Q-Ratio = 1.62 (Enterprise Value 16.96b / Total Assets 10.45b)
Interest Expense / Debt = 0.85% (Interest Expense 41.4m / Debt 4.87b)
Taxrate = 7.82% (4.41m / 56.4m)
NOPAT = 552.3m (EBIT 599.1m * (1 - 7.82%))
Current Ratio = 2.11 (Total Current Assets 4.70b / Total Current Liabilities 2.23b)
Debt / Equity = 1.37 (Debt 4.87b / totalStockholderEquity, last quarter 3.56b)
Debt / EBITDA = 6.16 (Net Debt 4.59b / EBITDA 744.6m)
Debt / FCF = 9.51 (Net Debt 4.59b / FCF TTM 482.8m)
Total Stockholder Equity = 1.97b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.65% (Net Income 399.7m / Total Assets 10.45b)
RoE = 20.31% (Net Income TTM 399.7m / Total Stockholder Equity 1.97b)
RoCE = 18.31% (EBIT 599.1m / Capital Employed (Equity 1.97b + L.T.Debt 1.30b))
RoIC = 17.12% (NOPAT 552.3m / Invested Capital 3.23b)
WACC = 6.62% (E(12.37b)/V(17.25b) * Re(8.92%) + D(4.87b)/V(17.25b) * Rd(0.85%) * (1-Tc(0.08)))
Discount Rate = 8.92% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -3.44%
[DCF] Terminal Value 82.29% ; FCFF base≈430.8m ; Y1≈394.1m ; Y5≈349.1m
[DCF] Fair Price = 21.20 (EV 8.52b - Net Debt 4.59b = Equity 3.92b / Shares 185.2m; r=6.62% [WACC]; 5y FCF grow -10.66% → 2.90% )
EPS Correlation: 38.13 | EPS CAGR: 6.43% | SUE: 0.22 | # QB: 0
Revenue Correlation: 30.08 | Revenue CAGR: 5.63% | SUE: 0.57 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.25 | Chg7d=-0.072 | Chg30d=-0.086 | Revisions Net=-2 | Analysts=8
EPS current Year (2026-12-31): EPS=4.31 | Chg7d=-0.196 | Chg30d=-0.204 | Revisions Net=-7 | Growth EPS=+22.9% | Growth Revenue=+69.5%
EPS next Year (2027-12-31): EPS=5.36 | Chg7d=-0.042 | Chg30d=-0.062 | Revisions Net=-2 | Growth EPS=+24.3% | Growth Revenue=+7.2%
[Analyst] Revisions Ratio: -0.50 (1 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.3% (Discount Rate 8.9% - Earnings Yield 4.6%)
[Growth] Growth Spread = +74.7% (Analyst 79.0% - Implied 4.3%)